Bio Rad Laboratories Stock Shares Outstanding
| BIO-B Stock | USD 265.82 0.00 0.00% |
Bio Rad Laboratories fundamentals help investors to digest information that contributes to Bio-Rad Laboratories' financial success or failures. It also enables traders to predict the movement of Bio-Rad Stock. The fundamental analysis module provides a way to measure Bio-Rad Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio-Rad Laboratories stock.
The current year's Common Stock Shares Outstanding is expected to grow to about 29.1 M.
Bio-Rad | Shares Outstanding |
Bio Rad Laboratories Company Shares Outstanding Analysis
Bio-Rad Laboratories' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Bio-Rad Laboratories Shares Outstanding | 5.07 M |
Most of Bio-Rad Laboratories' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Rad Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bio-Rad Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Bio-Rad Laboratories is extremely important. It helps to project a fair market value of Bio-Rad Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Bio-Rad Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bio-Rad Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bio-Rad Laboratories' interrelated accounts and indicators.
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBio-Rad Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
At present, Bio-Rad Laboratories' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Bio Rad Laboratories has 5.07 M of shares currently outstending. This is 97.19% lower than that of the Life Sciences Tools & Services sector and 96.45% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.11% higher than that of the company.
Bio-Rad Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio-Rad Laboratories' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio-Rad Laboratories could also be used in its relative valuation, which is a method of valuing Bio-Rad Laboratories by comparing valuation metrics of similar companies.Bio Rad is currently under evaluation in shares outstanding category among its peers.
Bio-Rad Fundamentals
| Return On Equity | -0.24 | ||||
| Return On Asset | 0.0155 | ||||
| Profit Margin | (0.72) % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 6.89 B | ||||
| Shares Outstanding | 5.07 M | ||||
| Shares Owned By Insiders | 98.04 % | ||||
| Shares Owned By Institutions | 0.08 % | ||||
| Number Of Shares Shorted | 34 | ||||
| Price To Earning | 17.05 X | ||||
| Price To Book | 1.13 X | ||||
| Price To Sales | 2.80 X | ||||
| Revenue | 2.57 B | ||||
| Gross Profit | 1.38 B | ||||
| EBITDA | (2.14 B) | ||||
| Net Income | (99.4 M) | ||||
| Cash And Equivalents | 858.99 M | ||||
| Cash Per Share | 28.81 X | ||||
| Total Debt | 174.3 M | ||||
| Debt To Equity | 13.90 % | ||||
| Current Ratio | 4.57 X | ||||
| Book Value Per Share | 234.53 X | ||||
| Cash Flow From Operations | 455.2 M | ||||
| Short Ratio | 0.94 X | ||||
| Earnings Per Share | (65.37) X | ||||
| Price To Earnings To Growth | 1.21 X | ||||
| Number Of Employees | 7.7 K | ||||
| Beta | 0.99 | ||||
| Market Capitalization | 7.18 B | ||||
| Total Asset | 9.36 B | ||||
| Retained Earnings | 7.42 B | ||||
| Working Capital | 2.56 B | ||||
| Net Asset | 9.36 B |
About Bio-Rad Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Rad Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio-Rad Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio-Rad Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.